Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldstein

Showing results (301-310 of 518) with videos related to

Pageof 52
Sort By:
JCO Precision Oncology|February 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε MutationBenjamin Koh, Subotheni Thavaneswaran, Frank Lin, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasDavid Goldstein, M Corona Gainford, Chris Brown, et al.
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
Head & Neck|March 22, 2017
Body mass index and prognosis in patients with head and neck cancerRicardo Ribeiro Gama, Yuyao Song, Qihuang Zhang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 18, 2016
Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal studyVanessa L Beesley, Leesa F Wockner, Peter O'Rourke, et al.
BMC Cancer|August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trialAlexander Stein, Dirk Arnold, John Bridgewater, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 8, 2016
Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal studyVanessa L Beesley, Leesa F Wockner, Peter O'Rourke, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Biomarker Insights|February 17, 2022
Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to SustainabilityCarmel M Quinn, Mamta Porwal, Nicola S Meagher, et al.
Pageof 52

Showing results (301-310 of 518) with videos related to

Sort By:
Pageof 52
JCO Precision Oncology|February 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε MutationBenjamin Koh, Subotheni Thavaneswaran, Frank Lin, et al.
Cancer Chemotherapy and Pharmacology|May 13, 2010
Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomasDavid Goldstein, M Corona Gainford, Chris Brown, et al.
Journal of Genetic Counseling|July 4, 2021
Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing studyPhyllis Butow, Grace Davies, Christine E Napier, et al.
JAMA Network Open|May 15, 2020
Assessment of the Value of Tumor Variation Profiling Perceived by Patients With CancerPhyllis Butow, Grace Davies, Christine E Napier, et al.
Head & Neck|March 22, 2017
Body mass index and prognosis in patients with head and neck cancerRicardo Ribeiro Gama, Yuyao Song, Qihuang Zhang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 18, 2016
Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal studyVanessa L Beesley, Leesa F Wockner, Peter O'Rourke, et al.
BMC Cancer|August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trialAlexander Stein, Dirk Arnold, John Bridgewater, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 8, 2016
Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal studyVanessa L Beesley, Leesa F Wockner, Peter O'Rourke, et al.
Psycho-Oncology|July 9, 2021
Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profilingPhyllis Butow, Fabiola Müller, Christine E Napier, et al.
Biomarker Insights|February 17, 2022
Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to SustainabilityCarmel M Quinn, Mamta Porwal, Nicola S Meagher, et al.
Pageof 52